Bristol Myers Squibb Co. Stock Outperforms Competitors On Strong Trading Day

Dow Jones

2025.12.04 21:40

I'm PortAI, I can summarize articles.

Bristol Myers Squibb Co. (BMY) stock rose 1.94% to $51.95, outperforming competitors in a mixed market session. The S&P 500 increased by 0.11%, while the Dow Jones fell by 0.07%. This marks the second consecutive day of gains for BMY, which remains 17.97% below its 52-week high. Trading volume was 19.8 million, surpassing the 50-day average of 16.9 million.

This article was automatically generated by MarketWatch using technology from Automated Insights. Shares of Bristol Myers Squibb Co. (BMY) advanced 1.94% to $51.95 Thursday, on what proved to be an all-around mixed trading session for the stock market, with the S&P 500 Index rising 0.11% to 6,857.12 and the Dow Jones Industrial Average falling 0.07% to 47,850.94. This was the stock's second consecutive day of gains. Bristol Myers Squibb Co. closed 17.97% short of its 52-week high of $63.33, which the company reached on March 11th. The stock outperformed some of its competitors Thursday, as Johnson & Johnson (JNJ) fell 1.39% to $202.48, Pfizer Inc. (PFE) rose 0.51% to $25.70, and Abbott Laboratories (ABT) rose 0.09% to $125.40. Trading volume (19.8 M) eclipsed its 50-day average volume of 16.9 M. Data source: Dow Jones Market Data, FactSet. Data compiled December 4, 2025. This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal. (END) Dow Jones Newswires 12-04-25 1640ET